Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003425291 | SCV004142080 | benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | BICRA: BS1, BS2 |
Ambry Genetics | RCV004364567 | SCV004914282 | uncertain significance | not specified | 2022-06-29 | criteria provided, single submitter | clinical testing | The c.3056C>T (p.P1019L) alteration is located in exon 9 (coding exon 7) of the GLTSCR1 gene. This alteration results from a C to T substitution at nucleotide position 3056, causing the proline (P) at amino acid position 1019 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |